A multidisciplinary PM&R practice can easily create hidden complexity. Therapy, electrodiagnostics, injectable drugs, psychological testing and behavioral health are not variations of one workflow. Each needs defined clinical prerequisites, payer rules, staffing, documentation, coding and escalation.
GOHEALTHCARE PM&R SPECIALTY GUIDE™
PM&R Clinical Services, Procedures and Diagnostic Testing
Operational orientation to PM&R therapy, electrodiagnostics, injections, tone management, cognitive testing, behavioral services and related diagnostics
Developed by Pinky Maniri, Founder & Chief Executive Officer, GoHealthcare Practice Solutions
CLINICAL SERVICES
Physiatry services, therapy, electrodiagnostics, injections, testing, rehabilitation and coordinated care.
OPERATIONAL FOCUS
Operational orientation to PM&R therapy, electrodiagnostics, injections, tone management, cognitive testing, behavioral services and related diagnostics
REFERENCE YEAR
2026 — verify current payer, coding, coverage and regulatory requirements before use.
GoHealthcare Operational Results
98%Company-reported prior authorization approval rate
50 StatesNational prior authorization and utilization-management support
PM&R FocusPhysiatry, rehabilitation therapy, diagnostics, functional outcomes, access and revenue-cycle operations
Company-reported performance. Results vary by client, payer, specialty, documentation quality, benefit design and case mix. No authorization or payment outcome is guaranteed.
Page Contents
Use the links below to move directly to the clinical, payer, documentation, coding, reimbursement, performance and operational sections.
Foundation & Core Guidance
Operations, Controls & Performance
- PM&R Clinical Service Matrix
- EMG and Nerve Conduction Studies
- Botulinum Toxin and Spasticity/Tone Management
- Viscosupplementation and Musculoskeletal Injection Services
- Psychological and Neuropsychological Testing
- Behavioral Health in PM&R
- Diagnostic Physiological and Functional Testing
- New Clinical Service Launch Checklist
- GoHealthcare Clinical Insights
- GoHealthcare Leadership Perspective
01
Clinical, Coverage, Documentation & Operations
Evidence at a Glance
PM&R clinical-service index for viscosupplementation, botulinum toxin, EMG/NCS, therapy, psychological and neuropsychological testing, behavioral health and related services.
| Domain | Summary (verify against current payer policy & date of service) |
|---|---|
| Service principle | Every PM&R clinical service needs its own indication, readiness, documentation, authorization, coding and revenue pathway. |
| Key services | Viscosupplementation, botulinum toxin, EMG/NCS, PT, OT, SLP, psychological/neuropsychological testing, behavioral health and selected functional testing. |
| Primary risk | Launching a service clinically before the benefit, authorization, product, coding, staffing and billing pathway is operationally ready. |
| Documentation driver | The record must show why the specific service is needed and what question or functional problem it is intended to address. |
| Authorization driver | Verify service, drug/product, unit/visit, reviewer, site and provider requirements separately. |
| Coding driver | Procedure, drug/product, units, guidance and diagnosis must match the performed service. |
| Launch standard | No new service goes live without a documented operating and revenue-integrity checklist. |
This page follows the GoHealthcare Clinical Procedure Guide information architecture: evidence first, then clinical and operational requirements, payer and authorization controls, coding/revenue integrity, GoHealthcare insight, case application, FAQs, key takeaways, future outlook and authoritative sources. Verify every payer, coding, regulatory and clinical statement against the controlling source at the point of use.
02
Clinical, Coverage, Documentation & Operations
Executive / Direct Answer
PM&R practices may combine physician evaluation, rehabilitation therapy, electrodiagnostic testing, selected injections, spasticity treatment, behavioral or cognitive services and injury management. Each service requires its own medical-necessity, authorization, documentation, coding and billing controls.
03
Clinical, Coverage, Documentation & Operations
Viscosupplementation
Operational controls should address payer and product coverage, diagnosis and joint criteria, prior conservative treatment, authorization, product sourcing, dose and units, frequency, documentation and claim reconciliation.
Coverage is not uniform across payers or products; verify the live policy and benefit for the patient.
04
Clinical, Coverage, Documentation & Operations
Botulinum Toxin Services
Common PM&R uses may include selected spasticity or dystonia-related indications within practitioner scope and payer policy. Controls should separate drug authorization from procedure authorization when required and track dose, units, wastage rules, product, lot and follow-up.
Clinical indications and coverage criteria must be verified against current payer and product requirements.
05
Clinical, Coverage, Documentation & Operations
Electromyography and Nerve Conduction Studies
EMG/NCS should answer a defined clinical question supported by history and examination. Workflow should control referral information, body region, laterality, authorization, provider qualification, study scope, complete reporting and claim accuracy.
Medicare coverage is often governed by MAC-specific LCDs and billing articles, so jurisdiction matters.
06
Clinical, Coverage, Documentation & Operations
Physical Therapy
PT focuses on movement, mobility, strength, balance, gait, endurance and functional performance. The dedicated PT page covers plans of care, authorization, timed services, progress, discharge, Medicare thresholds and denial prevention.
07
Clinical, Coverage, Documentation & Operations
Occupational Therapy
OT focuses on activities of daily living, upper-extremity function, cognition, adaptation, environmental modification and participation. The dedicated OT page covers discipline-specific documentation, billing and operational controls.
08
Clinical, Coverage, Documentation & Operations
Speech-Language Pathology
SLP may address speech, language, cognition, voice, fluency, feeding and swallowing depending on patient need and scope. The dedicated SLP page covers plans of care, authorization, coding, safety documentation and outcomes.
09
Clinical, Coverage, Documentation & Operations
Psychological and Neuropsychological Testing
Operational controls should identify the referral question, correct benefit, provider credentialing, authorization, test administration, scoring, interpretation, report completion, time components and privacy requirements.
Do not use testing as a generic prerequisite unless supported by clinical or payer requirements.
10
Clinical, Coverage, Documentation & Operations
Behavioral Health Services
Behavioral services may support chronic pain, adjustment, coping, function and rehabilitation participation. Verify carve-out arrangements, provider network status, authorization and privacy requirements.
Coordinate clinically relevant information without unnecessary disclosure of sensitive behavioral health content.
11
Clinical, Coverage, Documentation & Operations
Related Procedure Library Strategy
Each service should link to a deeper GoHealthcare procedure or service guide where coding, payer criteria, documentation and denial prevention are addressed in detail.
This specialty page remains the PM&R operating index rather than duplicating every procedure-specific rule.
12
Clinical, Coverage, Documentation & Operations
PM&R Clinical Service Matrix
| Service Family | Primary Readiness Domains | High-Risk Operational Failure |
|---|---|---|
| PT/OT/SLP | Order/referral, discipline benefit, authorization, plan of care, visits/units, progress and discharge. | Generic therapy workflow ignores discipline-specific rules or utilization. |
| EMG/NCS | Clinical question, history/exam, body region, provider qualification, payer/MAC policy, report. | Testing driven by a preset protocol or authorization rather than individualized clinical need. |
| Botulinum toxin/chemodenervation | Diagnosis, prior treatment, muscles/region, dose, procedure PA, drug PA, acquisition, frequency. | Procedure approved but product/dose pathway unresolved or units do not reconcile. |
| Viscosupplementation/joint injections | Joint/laterality, diagnosis, conservative care, product coverage, series/frequency, acquisition. | Preferred product, frequency or benefit rule missed. |
| Trigger point/other injections | Indication, region, documentation, payer policy, frequency and coding. | Clinical note does not support the service or repeat frequency. |
| Psychological/neuropsychological testing | Referral question, benefit manager, provider credential, instruments, units, report purpose. | Testing is ordered without a clear management question or correct benefit routing. |
| Behavioral health integration | Clinical indication, credentialing, privacy, benefit, care coordination and crisis escalation. | Behavioral information handled through general workflow without appropriate sensitivity or escalation. |
| DME/orthotics coordination | Order, supplier, coverage criteria, item, delivery, documentation and same/similar considerations. | Practice assumes equipment is covered because associated physician service is covered. |
13
Clinical, Coverage, Documentation & Operations
EMG and Nerve Conduction Studies
Electrodiagnostic evaluation should answer a clinical neuromuscular question. Referral intake should identify symptoms such as weakness, numbness, paresthesia, pain or cramping, the suspected region and relevant examination or imaging. Before scheduling, confirm payer authorization and any provider qualification or coverage restrictions.
AANEM describes electrodiagnostic evaluation as an extension of the neuromuscular examination and publishes resources concerning appropriate performance, interpretation and utilization. In operational terms, the study should be individualized by the qualified clinician; the report should document what was tested, normal and abnormal findings, interpretation and diagnostic conclusion; and the claim should reconcile to the report.
For Medicare, review the applicable MAC LCD and billing article if one governs the service. Commercial plans may impose their own medical policy or unit/utilization criteria. Repeat testing should have a clear clinical rationale and should not be performed simply because a new authorization can be obtained.
14
Clinical, Coverage, Documentation & Operations
Botulinum Toxin and Spasticity/Tone Management
Botulinum toxin workflows require coordination across clinical criteria, product acquisition and billing. The intake/PA team should confirm diagnosis, severity or functional impact, prior treatments, requested muscles or region as clinically appropriate, planned dose, product, frequency and whether the payer separates the procedure and drug authorizations.
Before service, reconcile the approval to the product and dose, ensure acquisition is complete and confirm any specialty-pharmacy requirements. The clinical record should support the indication, treatment plan, product, dose, sites, tolerance and follow-up. For repeat treatment, document response, duration of benefit, functional change and reason the next treatment remains appropriate under the current payer policy.
Inventory and billing systems should reconcile dose acquired, administered and discarded/wasted when relevant. The billing unit definition for the product must be verified rather than inferred from vial size.
15
Clinical, Coverage, Documentation & Operations
Viscosupplementation and Musculoskeletal Injection Services
Viscosupplementation coverage varies substantially by payer and product. The workflow should identify the affected joint and laterality, diagnosis, prior conservative treatment, prior injections or response, imaging/clinical evidence if required, preferred product restrictions, series/frequency limits and whether product sourcing is controlled.
Authorization should be linked to the exact approved product and dates when the payer specifies them. Product substitution after authorization should trigger review. The clinical documentation should support the patient-specific indication and service provided; a template copied across a series should still reflect the actual encounter and response.
Other musculoskeletal injections should be governed by procedure-specific coverage, documentation and coding rules. The GoHealthcare Procedure Library is the appropriate location for detailed procedure-level guidance and should be cross-linked from this specialty page.
16
Clinical, Coverage, Documentation & Operations
Psychological and Neuropsychological Testing
Start with the referral question: What clinical decision will the testing inform? Examples may include characterization of cognitive function, differential diagnosis, treatment planning or assessment relevant to a broader rehabilitation program. The exact service must remain within professional scope and payer coverage.
Verify whether the benefit is administered by the medical plan or behavioral health entity, which provider credentials are accepted, whether authorization is required and how testing administration, scoring, interpretation and report services are managed. The record should identify the reason for testing, instruments/services performed, findings, interpretation and implications for care.
Protect sensitive information. Access, disclosure and transmission should follow HIPAA and any additional applicable privacy requirements. Operational teams should not include unnecessary behavioral details in authorization or billing communications.
17
Clinical, Coverage, Documentation & Operations
Behavioral Health in PM&R
Behavioral health may affect pain coping, adherence, sleep, mood, adjustment to disability, return to work and participation in rehabilitation. Integration should be clinically purposeful rather than used as a generic screening step. Define referral criteria, crisis/safety escalation, information-sharing rules and feedback to the PM&R treatment plan.
Coverage may be carved out. Confirm provider network and credentialing before assuming an integrated practice can bill under the same medical-benefit workflow. Maintain clear boundaries between behavioral treatment, psychological testing and neuropsychological testing because their indications, credentials and billing structures differ.
18
Clinical, Coverage, Documentation & Operations
Diagnostic Physiological and Functional Testing
Any diagnostic test should have a defined question and an expected role in management. Avoid “testing because we have the equipment.” Before implementing a new test, evaluate evidence, regulatory status, professional qualification, payer coverage, code availability, supervision, site of service, report requirements and whether the result changes clinical management.
Unlisted or emerging technologies require particular care. Lack of a dedicated code does not establish noncoverage or coverage; it requires a deliberate coding and payer review. Marketing claims should remain consistent with evidence and regulatory status.
19
Clinical, Coverage, Documentation & Operations
New Clinical Service Launch Checklist
| Domain | Question Before Go-Live |
|---|---|
| Clinical | Who is appropriate, who is not, and what clinical competency is required? |
| Regulatory | What licensure, scope, supervision, facility or product rules apply? |
| Payer | Which plans cover the service and under what criteria/benefit? |
| Authorization | What documentation and workflow are required? |
| Documentation | Does the template capture indication, service details, response and required fields? |
| Coding | What current CPT/HCPCS/ICD-10, modifier, NCCI and unit logic applies? |
| Revenue | What is expected reimbursement, product cost, denial risk and contract behavior? |
| Compliance | What audit sample will be performed after launch? |
| Operations | Are staff, equipment, inventory, scheduling and emergency procedures ready? |
| Metrics | How will access, outcome, utilization, denial and financial performance be measured? |
20
GoHealthcare Operational Guidance
GoHealthcare Clinical Insights
GOHEALTHCARE CLINICAL INSIGHTS — EVERY CLINICAL SERVICE NEEDS ITS OWN READINESS AND REVENUE PATHWAY
21
GoHealthcare Operational Guidance
GoHealthcare Leadership Perspective
GOHEALTHCARE LEADERSHIP PERSPECTIVE — DO NOT LAUNCH THE CLINICAL SERVICE BEFORE THE OPERATING MODEL
Before a new service is marketed or scheduled, leadership should know who can perform it, where it can be performed, how it is authorized, what documentation is required, how supplies or drugs are acquired, how it is coded, and what denials or compliance risks are expected.
22
GoHealthcare Operational Guidance
GoHealthcare Prior Authorization Insight
GOHEALTHCARE PRIOR AUTHORIZATION INSIGHT — SERVICE AND PRODUCT AUTHORIZATION MAY BE DIFFERENT
For injectable therapies, the professional service and the drug/product can have separate coverage, sourcing or authorization requirements. Confirm both before treatment and retain the approval parameters for billing.
23
GoHealthcare Operational Guidance
GoHealthcare Case Study / Operational Scenario
Operational scenario. A practice adds botulinum toxin services and secures procedure authorization but does not consistently verify the product acquisition pathway. Some plans require specialty pharmacy while others allow buy-and-bill. The organization creates a payer-specific service-and-drug readiness matrix before scheduling, preventing avoidable inventory loss and claim denials.
This scenario is illustrative and is not represented as a specific patient case or guaranteed outcome.
24
GoHealthcare Operational Guidance
GoHealthcare Best Practices
- Verify the current authoritative source before operational reliance.
- Define the owner, minimum required data, readiness status and escalation rule.
- Reconcile the clinical record, authorization and final claim before billing.
- Track defects by root cause and feed them back to the workflow that produced them.
- Use AI and automation only within a governed process with human accountability.
GOHEALTHCARE BEST PRACTICES — BUILD THE CONTROL INTO THE WORKFLOW
The strongest PM&R organizations make the correct action easier to perform than the incorrect one. Standard work, structured data, readiness rules, pre-bill reconciliation and visible exceptions reduce dependence on memory and heroic follow-up.
25
GoHealthcare Operational Guidance
Common Mistakes
- Using generic payer rules instead of the patient’s current plan and product.
- Scheduling before all service-specific readiness requirements are complete.
- Allowing authorization, documentation, coding and billing data to diverge.
- Relying on copied or templated language without patient-specific clinical evidence.
- Fixing denials one case at a time without correcting the upstream defect.
26
GoHealthcare Operational Guidance
Pearls and Pitfalls
- Make the clinical purpose of the service unmistakable.
- Capture objective baseline data before measuring progress.
- Start authorization extensions before the existing approval is exhausted.
- Preserve source/version traceability for payer and coding decisions.
- Audit complete episodes periodically, not only individual notes or claims.
27
Clinical, Coverage, Documentation & Operations
Frequently Asked Questions
Why should PM&R services have separate workflows?
Because indication, payer benefit, authorization, documentation, coding, staffing and supplies differ by service.
Is EMG/NCS just another office diagnostic test?
No. It requires appropriate clinical indication, qualified performance/interpretation, detailed reporting and code selection based on the actual testing performed.
What should be checked before injectable therapy?
Clinical indication, coverage, authorization, product sourcing, dose/units, administration coding, documentation and plan-specific billing requirements.
Where do PT, OT and SLP fit?
They are distinct rehabilitation disciplines within the broader PM&R continuum and should have dedicated specialty pages and controls.
28
GoHealthcare Operational Guidance
Key Takeaways
- Every PM&R clinical service needs its own indication, readiness, documentation, authorization, coding and revenue pathway.
- Viscosupplementation, botulinum toxin, EMG/NCS, PT, OT, SLP, psychological/neuropsychological testing, behavioral health and selected functional testing.
- Launching a service clinically before the benefit, authorization, product, coding, staffing and billing pathway is operationally ready.
- The record must show why the specific service is needed and what question or functional problem it is intended to address.
- Verify service, drug/product, unit/visit, reviewer, site and provider requirements separately.
29
Policy, Evidence & Source Guidance
Future Outlook
- PM&R service lines will increasingly use digital intake and automated benefit/authorization checks.
- Product and specialty-pharmacy pathways will remain a major operational differentiator for injectable services.
- Diagnostic data will be integrated more tightly with care pathways and outcomes.
- New-service governance will become more formal as specialty organizations scale.
30
GoHealthcare Operational Guidance
Related GoHealthcare Resources
https://www.gohealthcarellc.com/physical-medicine-rehab-specialty-pmr-hub.htmlhttps://www.gohealthcarellc.com/pmr-specialty-overview.htmlhttps://www.gohealthcarellc.com/pmr-practice-operations.htmlhttps://www.gohealthcarellc.com/pmr-prior-authorization.htmlhttps://www.gohealthcarellc.com/pmr-revenue-cycle-management.htmlhttps://www.gohealthcarellc.com/pmr-clinical-documentation.htmlhttps://www.gohealthcarellc.com/pmr-coding-billing.htmlhttps://www.gohealthcarellc.com/pmr-compliance.htmlPM&R Specialty HubGoHealthcare MSK Specialty Procedure Library™Prior Authorization Resource CenterRevenue Cycle Management Resource CenterCase Study LibraryElectromyography (EMG)Nerve Conduction Studies (NCS)PM&R Clinical Guidelines
GOHEALTHCARE CODING INTELLIGENCE
Use the dedicated coding libraries for current code-family navigation and crosswalk methodology: PM&R CPT & HCPCS Coding Library, PM&R ICD-10-CM Diagnosis Crosswalk Library, and PM&R Modifiers, NCCI & MUE Reference. The service-specific page remains the controlling operational context.
31
Policy, Evidence & Source Guidance
Guidelines, Standards & Authoritative References
Applicable Guidelines, Coverage Policies and Professional Standards
GoHealthcare separates clinical guidance from coverage policy. A clinical practice guideline helps inform care; an LCD, NCD, billing article, payer medical policy or utilization-management rule determines coverage and administrative requirements for a specific payer, jurisdiction, benefit and date of service. Verify both layers before relying on this page operationally.
| Source | Guideline / Policy Resource | How to Use It Operationally |
|---|---|---|
| AANEM | Recommended EDX Policy | EMG/NCS quality, medical necessity and policy framework. |
| AAPM&R | Spasticity Guidance | Assessment and management framework for spasticity. |
| CMS | Botulinum Toxin LCD Example | Jurisdiction-specific coverage example; verify the patient's MAC. |
| VA/DoD | Low Back Pain CPG | Evidence-based MSK evaluation/treatment context. |
GUIDELINE CONTROL — DO NOT TREAT A LINK AS THE POLICY
Confirm the current version, effective date, patient payer/product, Medicare Administrative Contractor when applicable, state rules, site of service, provider qualifications and benefit limitations. Retired or superseded policies should remain in the audit trail but should not drive current authorization or billing decisions.
Authoritative sources; verify the current version and effective date before relying on any policy, coding, coverage or clinical requirement.
- https://www.aanem.org/clinical-practice-resources/advocacy/fraud-abuse/payer-resources. https://www.aanem.org/clinical-practice-resources/advocacy/fraud-abuse/payer-resources
- https://www.aanem.org/docs/default-source/documents/aanem/advocacy/2014-model-policy-ncs-emg. https://www.aanem.org/docs/default-source/documents/aanem/advocacy/2014-model-policy-ncs-emg
- https://www.cms.gov/medicare/coding-billing/therapy-services. https://www.cms.gov/medicare/coding-billing/therapy-services
- https://www.cms.gov/regulations-and-guidance/guidance/manuals/internet-only-manuals-ioms-items/cms012673. https://www.cms.gov/regulations-and-guidance/guidance/manuals/internet-only-manuals-ioms-items/cms012673
- https://www.cms.gov/regulations-and-guidance/guidance/manuals/internet-only-manuals-ioms-items/cms018912. https://www.cms.gov/regulations-and-guidance/guidance/manuals/internet-only-manuals-ioms-items/cms018912
- https://www.cms.gov/medicare-coverage-database/search.aspx. https://www.cms.gov/medicare-coverage-database/search.aspx
- https://www.cms.gov/medicare/coding-billing/national-correct-coding-initiative-ncci-edits. https://www.cms.gov/medicare/coding-billing/national-correct-coding-initiative-ncci-edits
- https://www.cms.gov/medicare/payment/fee-schedules/physician. https://www.cms.gov/medicare/payment/fee-schedules/physician
- https://www.hhs.gov/hipaa/for-professionals/index.html. https://www.hhs.gov/hipaa/for-professionals/index.html
- https://oig.hhs.gov/. https://oig.hhs.gov/
- https://www.aapmr.org/about-physiatry/about-physical-medicine-rehabilitation. https://www.aapmr.org/about-physiatry/about-physical-medicine-rehabilitation
- https://www.apta.org/. https://www.apta.org/
- https://www.aota.org/. https://www.aota.org/
- https://www.asha.org/. https://www.asha.org/
- Centers for Medicare & Medicaid Services. https://www.cms.gov/
- Medicare Coverage Database. https://www.cms.gov/medicare-coverage-database
- GoHealthcare Practice Solutions Knowledge Center. https://www.gohealthcarellc.com/
Clinical Services Coding Matrix: Therapy, EDX, Botulinum Toxin & Viscosupplementation
This coding matrix is an operational crosswalk, not a substitute for the current CPT codebook, HCPCS release, ICD-10-CM code set, Medicare NCCI files, payer policy or MAC article. Code descriptors below are deliberately paraphrased rather than reproduced verbatim.
CPT / HCPCS Level I Code Families
| Code | Operational use | Coding control |
|---|---|---|
| 95860–95870 / 95885–95887 / 95907–95913 | EMG/NCS families. | Same-day relationships and NCCI rules apply. |
| 64642–64647 | Extremity/trunk chemodenervation families. | Pair with actual toxin HCPCS product when appropriate. |
| 20610 / 20611 | Major-joint/bursa injection/aspiration families; 20611 includes ultrasound-guidance requirements in current CPT structure. | Verify code selection, imaging documentation and payer policy. |
| 97161–97168 | PT/OT evaluation/re-evaluation families. | Discipline and complexity specific. |
| 92507 / 92526 / 92610 | Selected SLP treatment/evaluation families. | Service-specific. |
Representative ICD-10-CM Diagnosis Crosswalk
| ICD-10-CM | Clinical context | Crosswalk control |
|---|---|---|
| M54.12 / M54.16 | Cervical/lumbar radiculopathy | Representative EDX indications. |
| G56.01–G56.03 | Carpal tunnel syndrome by laterality | Representative NCS/EMG indications. |
| G81.* / G82.* / I69.* | Spasticity/upper motor-neuron condition families | Select exact diagnosis supporting chemodenervation. |
| M17.11 / M17.12 | Unilateral knee osteoarthritis, right / left | Common hyaluronan indication context; payer criteria still control. |
HCPCS Level II Crosswalk
| HCPCS / Family | Operational use | Control |
|---|---|---|
| J0585–J0589 | Botulinum toxin product code families appearing in CMS MAC articles. | Product and units must match medication administered. |
| J7318 / J7320–J7332 | Hyaluronan product HCPCS families used for selected intra-articular products. | Exact product/unit definitions vary and can change annually; verify current HCPCS. |
| DME/O&P families | E-/K-/L-codes where equipment is furnished. | Supplier and coverage rules apply. |
Modifier Matrix
| Modifier | Use | Control |
|---|---|---|
| JW / JZ | Medicare discarded-drug reporting when applicable. | Document wastage/no wastage. |
| GP / GO / GN | Therapy plan modifiers. | Use by discipline. |
| CQ / CO | PTA/OTA modifiers when applicable. | Pair with GP/GO. |
| 59 / X modifiers | Distinct-service modifiers only when NCCI permits and record supports. | Never automatic. |
CODING CONTROL — VALID CODE ≠ COVERED SERVICE
A syntactically valid CPT, HCPCS or ICD-10-CM code does not establish medical necessity, authorization, benefit eligibility or payment. Reconcile diagnosis, procedure, units, modifiers, site of service, provider, authorization and current payer/MAC policy before billing.
Primary coding sources: CMS 2026 Therapy Code List · CMS NCCI · CMS MUE.
Build a Defensible, Scalable PM&R Workflow
GoHealthcare supports prior authorization, medical-necessity documentation, payer policy interpretation, coding and revenue integrity, appeals, PM&R operations and AI governance.
Developed By
Pinky Maniri
MSc, BSc, CRCR, CSAPM, CSPPM, CSBI, CSPR, CSAF, Certified in Healthcare A.I. Governance
Founder and Chief Executive Officer, GoHealthcare Practice Solutions
Educational and Operational Disclaimer
This content is provided for educational and operational planning purposes and is not medical, legal, coding, reimbursement or payer-contract advice. Coverage, authorization, coding, payment and clinical requirements vary by patient, plan, product, jurisdiction, Medicare Administrative Contractor, date of service, setting and current policy. Verify the controlling source before scheduling, authorization, billing, appeal or clinical decision-making. Authorization does not guarantee coverage or payment.
GoHealthcare Knowledge Center
Search GoHealthcare Practice Solutions
Search our procedure library, specialty guides, prior authorization resources, revenue cycle guidance, case studies, AI governance content, compliance resources and healthcare operations insights.